Sign in

CIK 0001501697 · Non-accelerated filer<br>Smaller reporting company

X4 Pharmaceuticals, Inc

Sign in to watch
Ticker
XFOR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273181608
Phone
857-529-8300
Business address
61 NORTH BEACON STREET, 4TH FLOOR, BOSTON, MA, 02134
Former names
Arsanis, Inc.
  1. 4 Grant or award Director acquired 45,000 shares (grant or award)
  2. 4 Grant or award Director acquired 45,000 shares (grant or award)
  3. 4 Grant or award Director acquired 45,000 shares (grant or award)
  4. 4 Grant or award Director acquired 45,000 shares (grant or award)
  5. 4 Open-market sale President and CEO sold 6,292 shares at $1.95 ($12,269)
  6. 4 Open-market sale Chief Operating Officer sold 18,192 shares at $0.84 ($15,281)
  7. 4 Open-market sale Chief Financial Officer sold 52,500 shares at $0.84 ($44,100)
  8. 4 Insider Changes in Ownership
  9. 4 Insider Changes in Ownership
  10. 4 Insider Changes in Ownership
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 4 Insider Changes in Ownership

Page 6 of 17 · 329 filings